These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 29966690)
1. Two sides of a coin: GG genotype of C7 provides protection against fibrosis severity while showing a higher risk for hepatocellular carcinoma in patients with hepatitis C. de Lima RE; de Holanda Martins CM; do Carmo RF; Aroucha DCBL; Pereira LMMB; Vasconcelos LRS; Moura P Hum Immunol; 2018 Sep; 79(9):702-707. PubMed ID: 29966690 [TBL] [Abstract][Full Text] [Related]
2. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients. Elsayed HM; Nabiel Y; Sheta T Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525 [TBL] [Abstract][Full Text] [Related]
3. Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study. Yen YH; Tsai MC; Wu CK; Chang KC; Hung CH; Chiu KW; Lu SN; Wang JH; Chen CH; Kee KM; Kuo YH; Tseng PL; Lin MT; Huang CM; Lin JT; Hu TH J Formos Med Assoc; 2018 Sep; 117(9):833-840. PubMed ID: 29089161 [TBL] [Abstract][Full Text] [Related]
4. Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population. Jiang Z; Jiang Q; Fang X; Wang P; Que W; Li H; Yu Y; Liu X; Wang C; Zhong L BMC Cancer; 2021 May; 21(1):521. PubMed ID: 33964921 [TBL] [Abstract][Full Text] [Related]
5. Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis. Wirtz TH; Fischer P; Backhaus C; Bergmann I; Brandt EF; Heinrichs D; Koenen MT; Schneider KM; Eggermann T; Kurth I; Stoppe C; Bernhagen J; Bruns T; Fischer J; Berg T; Trautwein C; Berres ML Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370326 [TBL] [Abstract][Full Text] [Related]
6. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients. Sghaier I; Mouelhi L; Rabia NA; Alsaleh BR; Ghazoueni E; Almawi WY; Loueslati BY Cytokine; 2017 Jan; 89():62-67. PubMed ID: 28340949 [TBL] [Abstract][Full Text] [Related]
7. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma. ELBassuoni MA; Abd El Fatah G; Zaghla H Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076 [TBL] [Abstract][Full Text] [Related]
8. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia. Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Khalaf NZ; Al-Ahdal MN; Al-Qahtani AA BMC Infect Dis; 2014 Dec; 14():632. PubMed ID: 25551790 [TBL] [Abstract][Full Text] [Related]
9. Low Molecular Mass Polypeptide 7 Single Nucleotide Polymorphism is Associated with the Progression of Liver Fibrosis in Patients Infected with Hepatitis C Virus Genotype 4. El Awady MK; Omran MH; Ibrahim MK; Moustafa AM; Dawood RM; Bader El Din NG; Elsharkawy A; Abdel Aziz MS; El Shenawy R; El Abd YS; Abdel Aziz AO Clin Lab; 2016; 62(3):381-7. PubMed ID: 27156327 [TBL] [Abstract][Full Text] [Related]
10. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C. Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195 [TBL] [Abstract][Full Text] [Related]
11. Association of Catalase and Glutathione Peroxidase 1 Polymorphisms with Chronic Hepatitis C Outcome. Sousa VC; Carmo RF; Vasconcelos LR; Aroucha DC; Pereira LM; Moura P; Cavalcanti MS Ann Hum Genet; 2016 May; 80(3):145-53. PubMed ID: 26990426 [TBL] [Abstract][Full Text] [Related]
12. TNF-α and IL-10 polymorphisms increase the risk to hepatocellular carcinoma in HCV infected individuals. Aroucha DC; Carmo RF; Vasconcelos LR; Lima RE; Mendonça TF; Arnez LE; Cavalcanti Mdo S; Muniz MT; Aroucha ML; Siqueira ER; Pereira LB; Moura P; Pereira LM; Coêlho MR J Med Virol; 2016 Sep; 88(9):1587-95. PubMed ID: 26890368 [TBL] [Abstract][Full Text] [Related]
13. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C. Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201 [TBL] [Abstract][Full Text] [Related]
14. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206 [TBL] [Abstract][Full Text] [Related]
15. A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection. Ali M; Yopp A; Gopal P; Beg MS; Zhu H; Lee W; Singal AG Clin Gastroenterol Hepatol; 2016 Feb; 14(2):295-300. PubMed ID: 26305067 [TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma. Labib HA; Ahmed HS; Shalaby SM; Wahab EA; Hamed EF Cell Immunol; 2015 Mar; 294(1):21-4. PubMed ID: 25666505 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study. Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333 [TBL] [Abstract][Full Text] [Related]
18. Association of thrombogenic genes polymorphisms with hepatocellular carcinoma in HCV Egyptian patients. Hanafy AS; Alaa FA; Randa MH Gene; 2016 Apr; 580(1):37-40. PubMed ID: 26768578 [TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase gene polymorphism predicts fibrosis severity in women with hepatitis C. do Carmo RF; Vasconcelos LR; Mendonça TF; de Mendonça Cavalcanti Mdo S; Pereira LM; Moura P Hum Immunol; 2014 Aug; 75(8):766-70. PubMed ID: 24882572 [TBL] [Abstract][Full Text] [Related]
20. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection. Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]